Location History:
- Summit, NJ (US) (2018)
- Stockton, NJ (US) (2004 - 2023)
Company Filing History:
9 out of 245 
3 out of 320 
2 out of 16,338 
Years Active: 2004-2023
Title: The Innovative Contributions of Keith A. Freehauf: A Pioneer in Pharmaceutical Advancements
Introduction: Keith A. Freehauf, an accomplished inventor based in Summit, NJ, has made significant contributions to the field of pharmaceuticals with a focus on isoxazoline compounds. With a total of 16 patents to his name, Freehauf has played a crucial role in developing effective solutions for controlling parasite infections in animals.
Latest Patents: Among his latest patents are groundbreaking formulations for solid oral pharmaceutical compositions designed for the delivery of isoxazoline compounds. This invention outlines a solid oral pharmaceutical composition consisting of a pharmaceutically acceptable active ingredient tailored for animals. It includes a combination of an isoxazoline compound, a solvent, and an excipient, providing a method to control parasite infections through oral administration. Additionally, Freehauf has developed implantable pharmaceutical compositions that serve as an effective means of controlling parasites in livestock. This innovation involves an implant that comprises one or more pellets containing an isoxazoline compound and a pharmaceutically acceptable excipient, offering a method for preventing or treating parasite infestations.
Career Highlights: Keith A. Freehauf has significantly impacted the pharmaceutical industry over the years, particularly through his work with notable companies like Intervet Inc. and Merial Limited. His expertise in the field has guided advancements in veterinary medicine and the development of safer, more effective treatments for animal health.
Collaborations: Throughout his career, Freehauf has collaborated with esteemed colleagues such as Robert D. Simmons and Kanwal Jit Varma. These collaborations have fostered innovation and contributed to the successful development of new pharmaceutical products aimed at enhancing animal welfare.
Conclusion: Keith A. Freehauf stands out as a notable inventor whose work in the pharmaceutical sector has greatly improved animal health care. His latest innovations in solid oral and implantable isoxazoline pharmaceutical compositions have not only showcased his ingenuity as an inventor but also underline his commitment to addressing significant challenges in veterinary medicine. With 16 patents to his credit, Freehauf continues to be a driving force in the quest for effective solutions in the battle against parasite infestations in livestock.